More Than 130 Healthcare Groups Express Support for Legislation Expanding Medicare Patients Access to Pharmacist Services
News provided by
Share this article
Share this article
WASHINGTON, May 25, 2021 /PRNewswire/ Today, more than 130 healthcare groups applauded the introduction of the Pharmacy and Medically Underserved Areas Enhancement Act (S. 1362, H.R. 2759), legislation that will ensure that Medicare beneficiaries in medically underserved areas have access to pharmacists primary care services.
In a letter sent to the bill s original sponsors Sen. Chuck Grassley (R-IA), Sen. Bob Casey (D-PA), Sen. Sherrod Brown (D-OH), Rep. G.K. Butterfield (D-NC), and Rep. David McKinley (R-WV) the healthcare groups, including rural health advocates, consumer groups, and pharmacy organizations, call for the removal of restrictions on seniors access to care.
Safety of Oral DMTs for RRMS in Real-world Use Match Trial Findings multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.
EAGAN, Minn., April 12, 2021 /PRNewswire/ Blue Cross and Blue Shield plans can better forecast and manage the total cost of chimeric antigen receptor T-cell (CAR-T) therapies for members
Share this article
Share this article
EAGAN, Minn., April 7, 2021 /PRNewswire/ Armed with insights from substantive, real-world data, Blue Cross and Blue Shield plans that partner with Prime Therapeutics LLC (Prime) are now more effectively making data-driven decisions to mitigate the high costs of autoimmune therapies for inflammatory conditions and multiple sclerosis (MS). Recently, Prime analyzed integrated pharmacy and medical claims data for specialty drug use in autoimmune conditions – the top cost drivers among all drug health care expenses. At 22% of all drug expenditures through the medical and pharmacy benefits among Prime s commercially insured book of business, autoimmune therapy costs for inflammatory conditions and MS account for $6.7 billion annually.